Morimoto Y - Search Results

1

General pharmacology of KB-944, a new calcium antagonist.

Morita T, Fukuda T, Sukamoto T, Tajima S, Sato I, Ikeda Y, Kanazawa T, Hamada Y, Morimoto Y, Kitamura H, Kawakami K, Ito K, Nose T. Morita T, et al. Among authors: morimoto y. Arzneimittelforschung. 1982;32(9):1060-8. Arzneimittelforschung. 1982. PMID: 6890827 No abstract available.

2

General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 1st communication: effects on the central nervous system.

Saito T, Fukuda T, Sukamoto T, Yoshidomi M, Morimoto Y, Shimohara K, Ito K. Saito T, et al. Among authors: morimoto y. Arzneimittelforschung. 1988 Jan;38(1):66-9. Arzneimittelforschung. 1988. PMID: 2896509

3

General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 2nd communication: Effects on the circulation and the other systems.

Saito T, Fukuda T, Tajima S, Sukamoto T, Yamashita A, Kanazawa T, Morimoto Y, Shimohara K, Nishimura N, Yokota K, et al. Saito T, et al. Among authors: morimoto y. Arzneimittelforschung. 1988 Feb;38(2):267-72. Arzneimittelforschung. 1988. PMID: 2897196

4

Effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimida zole difumarate (KB-2413), a new antiallergic, on chemical mediators.

Fukuda T, Morimoto Y, Iemura R, Kawashima T, Tsukamoto G, Ito K. Fukuda T, et al. Among authors: morimoto y. Arzneimittelforschung. 1984;34(7):801-5. Arzneimittelforschung. 1984. PMID: 6149754

5

Pharmacological properties of 6-(o-chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo[3,4-c]thieno[2,3-e] [1,4]diazepine (Y-7131), a new anti-anxiety drug.

Tsumagari T, Nakajima A, Fukuda T, Shuto S, Kenjo T, Morimoto Y, Takigawa Y. Tsumagari T, et al. Among authors: morimoto y. Arzneimittelforschung. 1978;28(7):1158-64. Arzneimittelforschung. 1978. PMID: 39570

6

Effects of KB-5492, a new anti-ulcer agent, on ethanol- and acidified aspirin-induced gastric mucosal damage in vivo and in vitro.

Morimoto Y, Oshima S, Hara H, Sukamoto T. Morimoto Y, et al. Jpn J Pharmacol. 1994 Jan;64(1):41-7. doi: 10.1254/jjp.64.41. Jpn J Pharmacol. 1994. PMID: 8164392 Free article.

7

Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of teprenone and cimetidine.

Morimoto Y, Shimohara K, Oshima S, Sukamoto T. Morimoto Y, et al. Jpn J Pharmacol. 1991 Dec;57(4):495-505. doi: 10.1254/jjp.57.495. Jpn J Pharmacol. 1991. PMID: 1803065 Free article.

8

Effects of KB-5492, a new anti-ulcer agent with a selective affinity for the sigma-receptor, on aspirin-induced disruption of the rat gastric mucosal barrier.

Morimoto Y, Shimohara K, Oshima S, Hara H, Sukamoto T. Morimoto Y, et al. Jpn J Pharmacol. 1994 Jan;64(1):49-55. doi: 10.1254/jjp.64.49. Jpn J Pharmacol. 1994. PMID: 8164393 Free article.

9

4-Methoxyphenyl 4-(3,4,5-trimethoxybenzyl)-1-piperazineacetate monofumarate monohydrate (KB-5492), a new anti-ulcer agent with a selective affinity for the sigma receptor, prevents cysteamine-induced duodenal ulcers in rats by a mechanism different from that of cimetidine.

Morimoto Y, Shimohara K, Tanaka K, Hara H, Sukamoto T. Morimoto Y, et al. Jpn J Pharmacol. 1994 Mar;64(3):221-4. doi: 10.1254/jjp.64.221. Jpn J Pharmacol. 1994. PMID: 8022123 Free article.

10

[Effect of nizofenone (Y-9179) on experimental cerebral ischemia in Mongolian gerbils].

Morimoto Y, Fukuda T, Tsumagari T. Morimoto Y, et al. Nihon Yakurigaku Zasshi. 1984 Jun;83(6):507-11. Nihon Yakurigaku Zasshi. 1984. PMID: 6489862 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,429 results

Search Page

Filters